MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Microglial activation facilitates alpha synuclein propagation and neurodegeneration in αSyn preformed fibrils (PFF)-injected PD mouse model

    YE. Kim, TT. Lai, F. Richter, HI. Ma (Anyang, Republic of Korea)

    Objective: To evaluate whether microglial activation aggravates synucleinopathy progression in Parkinson's disease (PD) mouse model. Background: Alpha-synuclein (αSyn) accumulation underlay the main pathological process of…
  • 2022 International Congress

    Effect of lower limb vs. abdominal compression on mobility in orthostatic hypotension – a single-blinded, randomized, controlled, cross-over study in Parkinson’s disease

    S. Paschen, C. Hansen, J. Welzel, J. Albrecht, A. Atresaei, K. Aminian, KE. Zeuner, R. Romijnders, E. Warmerdam, PP. Urban, D. Berg, W. Maetzler (Kiel, Germany)

    Objective: Orthostatic hypotension (OH) in Parkinson’s disease (PD) is frequent and associated with reduced quality of life and reduced activities of daily living. Abdominal binders…
  • 2022 International Congress

    Neuroprotective effects of Ibudilast, a Phosphodiesterase IV inhibitor in mouse model of Parkinson’s disease

    M. Sarswati, A. Gaur (Delhi, India)

    Objective: In the present study, we examined neuroprotective effects, if any, of IBD drug, a  inhibitor of the phosphodiesterase IV in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse…
  • 2022 International Congress

    Mutation screening and burden analysis of MED27 in dystonia in a Chinese population

    J. Lin, C. Li, H. Shang (Chengdu, China)

    Objective: We aimed to systematically evaluate the genetic associations of MED27with dystonia in a dystonia cohort. Background: Recently,Meng et alreported a novel neurodevelopmental syndrome manifested homogeneously as…
  • 2022 International Congress

    DaTscan striatal binding ratio dynamics in mutations carriers at risk for Parkinson’s disease: A 2-year prospective study

    A. Droby, D. Atias, H. Lerman, RM. Hutchison, L. Yahimovich, J. Cedarbaum, E. Even Sapir, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)

    Objective: To investigate the temporal dynamics of striatal binding ratios (SBRs) among individuals with Parkinson's disease (PD)-related mutations and its' association with likelihood ratio (LR)…
  • 2022 International Congress

    Longitudinal white matter microstructural changes in the prodromal phase of PD: A 2 year prospective study

    A. Droby, A. Yoffe-Vasiliev, RM. Hutchison, S. Paz, J. Cedarbaum, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)

    Objective: To prospectively investigate white matter (WM) alterations in non-manifesting carriers (NMCs) of Parkinson's disease (PD)-related mutations, and its association with likelihood ratio (LR) scores.…
  • 2022 International Congress

    Post deep brain stimulation cognitive decline in GBA-related Parkinson’s disease

    C. Weill, A. Gallant, E. Linetsky, Z. Israel, D. Arkadir (jerusalem, Israel)

    Objective: Neurocognitive deterioration study in GBA-related Parkinson’s disease (GBA-PD) following Deep Brain stimulation Surgery of the Sub Thalamic Nuclei (STN-DBS) Background: A faster progress of Parkinson’s…
  • 2022 International Congress

    Merging global cohorts of manifesting and non-manifesting carriers of pathogenic variants in known Parkinson’s disease genes

    K. Roopnarain, E. Vollstedt,, L. Lange, S. Padmanabhan, C. Blauwendraat, A. Singleton, K. Katja, C. Klein (Luebeck, Germany)

    Objective: To create a global cohort of manifesting and non-manifesting carriers of pathogenic variants in known monogenic Parkinson's disease (PD) genes, such as LRRK2, PRKN, and PINK1, to better…
  • 2022 International Congress

    A child with infantile onset paroxysmal episodes of jerks and stiff limbs

    A. Das, A. Elavarasi, R. Singh, D. Vibha, M. Tripathi (Delhi, India)

    Objective: To present a child with ADCY5 related movement disorder having clinical response to steroids. Background: A 17 year old female, with delayed developmental milestones…
  • 2022 International Congress

    Development of a quality-of-life (QoL) questionnaire for hereditary spastic paraplegia (HSP) patients and caregivers.

    J. Malina, B. Schröder, E. Hüßler, T. Kühl, S. Klebe (Essen, Germany)

    Objective: Patient reported outcomes like “Health-Related Quality of Life” are one of the key outcome parameters of clinical studies. The aim of this project within…
  • « Previous Page
  • 1
  • …
  • 379
  • 380
  • 381
  • 382
  • 383
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley